Laurence Reid - 15 Sep 2021 Form 4 Insider Report for Decibel Therapeutics, Inc. (DBTX)

Role
President and Chief Executive, Director
Signature
/s/ Laurence Reid
Issuer symbol
DBTX
Transactions as of
15 Sep 2021
Transactions value $
$76,400
Form type
4
Filing time
17 Sep 2021, 21:48:07 UTC
Next filing
28 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DBTX Common Stock Purchase $76.4K +10K +63.1% $7.64 25.8K 15 Sep 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.587 to $7.65, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.